We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+7.29%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$22.1B
AUM Growth
+$302M
Cap. Flow
-$1.3B
Cap. Flow %
-5.9%
Top 10 Hldgs %
11.41%
Holding
3,562
New
1,146
Increased
641
Reduced
606
Closed
971

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$148M
2
NFLX icon
Netflix
NFLX
+$119M
3
ABNB icon
Airbnb
ABNB
+$111M
4
XYZ
Block Inc
XYZ
+$89.5M
5
DHR icon
Danaher
DHR
+$88.6M

Top Sells

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$212M
2
BABA icon
Alibaba
BABA
+$172M
3
ZTS icon
Zoetis
ZTS
+$133M
4
TRU icon
TransUnion
TRU
+$124M
5
BIDU icon
Baidu
BIDU
+$111M

Sector Composition

Rank Sector Weight
1 Healthcare 20.88%
2 Financials 13.4%
3 Consumer Discretionary 12.06%
4 Technology 11.2%
5 Communication Services 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATIP
851
DELISTED
ATI Physical Therapy, Inc.
ATIP
$4.85M 0.02%
10,172
-9,320
-48% -$4.61M
TZPS
852
DELISTED
TZP Strategies Acquisition Corp. Class A Ordinary Share
TZPS
$4.85M 0.02%
499,974
STT icon
853
State Street
STT
$50.9B
$4.84M 0.02%
58,851
-76,036
-56% -$6.42M
MTLS
854
Materialise
MTLS
$379M
$4.84M 0.02%
+200,798
New +$5.63M
GXIIW
855
CALL
DELISTED
GX Acquisition Corp. II Warrant
GXIIW
$4.83M 0.02%
+499,961
New +$395K
NRAC
856
DELISTED
Northern Revival Acquisition Corporation Class A Ordinary Share
NRAC
$4.83M 0.02%
+499,896
New +$4.86M
KWEB icon
857
KraneShares CSI China Internet ETF
KWEB
$5.2B
$4.83M 0.02%
+69,214
New +$4.98M
CHAA
858
DELISTED
Catcha Investment Corp
CHAA
$4.83M 0.02%
+499,983
New +$4.88M
ANF icon
859
Abercrombie & Fitch
ANF
$4.17B
$4.82M 0.02%
103,697
-62,182
-37% -$2.51M
NDAC
860
DELISTED
NightDragon Acquisition Corp. Class A Common stock
NDAC
$4.8M 0.02%
+491,555
New +$4.82M
CAHC
861
DELISTED
CA Healthcare Acquisition Corp. Class A Common Stock
CAHC
$4.79M 0.02%
484,852
INMD icon
862
InMode
INMD
$872M
$4.79M 0.02%
101,162
+67,858
+204% +$2.88M
GRFS
863
Grifois
GRFS
$5.16B
$4.77M 0.02%
275,031
-604,527
-69% -$10.8M
RVTY icon
864
Revvity
RVTY
$12.3B
$4.77M 0.02%
30,899
-22,154
-42% -$3.11M
PNTM.WS
865
CALL
DELISTED
Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PNTM.WS
$4.77M 0.02%
490,330
+202,952
+71% +$168K
MIT.WS
866
CALL
DELISTED
Mason Industrial Technology, Inc. Redeemable warrants, exercisable for one share of Class A common stock for $11.50 per share
MIT.WS
$4.76M 0.02%
+492,822
New +$374K
SB icon
867
Safe Bulkers
SB
$781M
$4.76M 0.02%
1,186,283
+1,022,091
+622% +$3.58M
IT icon
868
Gartner
IT
$9.41B
$4.75M 0.02%
19,622
-24,926
-56% -$5.45M
HLF icon
869
Herbalife
HLF
$1.23B
$4.75M 0.02%
+90,017
New +$4.48M
IEF icon
870
PUT
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
$4.74M 0.02%
41,000
-19,500
-32% -$2.23M
COHR
871
DELISTED
Coherent Inc
COHR
$4.73M 0.02%
17,899
-44,700
-71% -$11.8M
JLL icon
872
Jones Lang LaSalle
JLL
$15.1B
$4.73M 0.02%
24,187
+11,179
+86% +$2.18M
MLAB icon
873
Mesa Laboratories
MLAB
$539M
$4.71M 0.02%
17,378
+156
+0.9% +$39.6K
PTRAW
874
CALL
DELISTED
Proterra Inc. Warrant
PTRAW
$4.71M 0.02%
274,996
-29,012
-10% -$153K
COVAW
875
CALL
DELISTED
COVA Acquisition Corp. Warrants to purchase Class A ordinary shares
COVAW
$4.7M 0.02%
+485,302
New +$338K

Similar funds

Marshall Wace's Q2 2021 Portfolio in Review

As of Q2 2021, Marshall Wace held 3,562 positions worth $22.1B, up 1.4% from $21.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Marshall Wace withdrew a net $1.3B in Q2 2021, closing 971 positions and reducing 606 holdings. Its most notable exit was Pinterest, an estimated $88.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Marshall Wace opened a new position in West Pharmaceutical worth $55.8M.

  • Marshall Wace's largest Q2 2021 buy was West Pharmaceutical: 155,316 shares worth $55.8M.
  • Marshall Wace added most to Biogen in Q2 2021, an estimated $148M increase.
  • Marshall Wace's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $212M.
  • Marshall Wace fully exited Pinterest in Q2 2021, selling an estimated $88.8M.
  • Marshall Wace's ten largest holdings make up 11% of its $22.1B portfolio in Q2 2021.
  • Marshall Wace opened 1,146 new positions and closed 971 in Q2 2021.
  • Marshall Wace's portfolio value rose 1.4% quarter-over-quarter to $22.1B.

Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.